Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabectedin + Olaparib in Advanced Sarcoma
NCT04076579Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Mar 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in sarcoma, sponsored by University of Michigan Rogel Cancer Center. Started Mar 2020; status: completed.
02
Drugs
olaparib
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT04076579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04076579.